Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...
Ocugen (NASDAQ:OCGN) presented top-line 12-month results from its Phase II ArMaDa clinical trial evaluating OCU410, a ...
Honeywell International (HON) chairman and CEO Vimal Kapur sits down with Yahoo Finance Anchor Julie Hyman at the CERAWeek ...
Today, threat actors are quietly collecting data, waiting for the day when that information can be cracked with future technology.
Cybercriminals are implementing zero-day exploits a week before patches become available, according to a new report from ...
The pop culture reference's roots run deeper than you may think, but Witch-and ManifestationTok changed the game.
We tend to think of infrastructure as physical or technical systems: roads, power grids, cloud platforms. But infrastructure ...
Salesforce recently completed an ambitious plan to migrate the Informatica Help system to the Salesforce AgentForce ...
A new hacking group has been rampaging the Internet in a persistent campaign that spreads a self-propagating and never-before ...
Attachment to smart devices and biometric surveillance leaves Americans more vulnerable to police searches than ever. Left ...
Ares Capital is a great choice for income investors at this price. Click here to find out why ARCC stock is a Buy.
Navigating innovation, regulation, and sovereignty as enterprises build resilient AI-ready data architectures worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results